Literature DB >> 26172150

Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion.

Cynthia R Fata1, Eric A Gehrie2, Pampee P Young3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26172150     DOI: 10.1111/trf.13119

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  1 in total

1.  Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation.

Authors:  Luca Lanfranco; Melanie Joly; Arnaud Del Bello; Laure Esposito; Noelle Cognard; Peggy Perrin; Bruno Moulin; Nassim Kamar; Sophie Caillard
Journal:  Case Rep Transplant       Date:  2017-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.